Skip to main navigation Skip to search Skip to main content

Copy-number variants and polygenic risk for intelligence confer risk for autism spectrum disorder irrespective of their effects on cognitive ability

  • Zoe Schmilovich
  • , Vincent Raphaël Bourque
  • , Elise Douard
  • , Guillaume Huguet
  • , Cécile Poulain
  • , Jay P. Ross
  • , Paria Alipour
  • , Charles Étienne Castonguay
  • , Nadine Younis
  • , Martineau Jean-Louis
  • , Zohra Saci
  • , Zdenka Pausova
  • , Tomas Paus
  • , Gunter Schuman
  • , David Porteous
  • , Gail Davies
  • , Paul Redmond
  • , Sarah E. Harris
  • , Ian J. Deary
  • , Heather Whalley
  • Caroline Hayward, Patrick A. Dion, Sébastien Jacquemont, Guy A. Rouleau*
*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Introduction: Rare copy number variants (CNVs) and polygenic risk for intelligence (PRS-IQ) both confer susceptibility for autism spectrum disorder (ASD) but have opposing effects on cognitive ability. The field has struggled to disentangle the effects of these two classes of genomic variants on cognitive ability from their effects on ASD susceptibility, in part because previous studies did not include controls with cognitive measures. We aim to investigate the impact of these genomic variants on ASD risk while adjusting for their known effects on cognitive ability. Methods: In a cohort of 8,426 subjects with ASD and 169,804 controls with cognitive assessments, we found that rare coding CNVs and PRS-IQ increased ASD risk, even after adjusting for their effects on cognitive ability. Results: Bottom decile PRS-IQ and CNVs both decreased cognitive ability but had opposing effects on ASD risk. Models combining both classes of variants showed that the effects of rare CNVs and PRS-IQ on ASD risk and cognitive ability were largely additive, further suggesting that susceptibility for ASD is conferred independently from its effects on cognitive ability. Despite imparting mostly additive effects on ASD risk, rare CNVs and PRS-IQ showed opposing effects on core and associated features and developmental history among subjects with ASD. Discussion: Our findings suggest that cognitive ability itself may not be the factor driving the underlying liability for ASD conferred by these two classes of genomic variants. In other words, ASD risk and cognitive ability may be two distinct manifestations of CNVs and PRS-IQ. This study also highlights the challenge of understanding how genetic risk for ASD maps onto its dimensional traits.
Original languageEnglish
Article number1369767
JournalFrontiers in Psychiatry
Volume15
Early online date1 May 2024
DOIs
Publication statusPublished - 2024

Keywords / Materials (for Non-textual outputs)

  • ASD autism spectrum disorders
  • CNV (copy number variant)
  • cognitive abilities
  • intelligence quotient (IQ)
  • polygenic risk score (PRS)

Fingerprint

Dive into the research topics of 'Copy-number variants and polygenic risk for intelligence confer risk for autism spectrum disorder irrespective of their effects on cognitive ability'. Together they form a unique fingerprint.

Cite this